| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 5619469 | Pregnancy Hypertension: An International Journal of Women's Cardiovascular Health | 2016 | 4 Pages |
Abstract
Hydroxychloroquine is an anti-malarial drug which, due to its anti-inflammatory and immunomodulatory effects, is widely used for the treatment of autoimmune diseases. In a model of systemic lupus erythematosus hydroxychloroquine has been shown to exert protective endothelial effects. In this study, we aimed to investigate whether hydroxychloroquine was endothelial protective in an in vitro model of TNF-α and preeclamptic serum induced dysfunction. We showed that hydroxychloroquine significantly reduced the production of TNF-α and preeclamptic serum induced endothelin-1 (ET-1). Hydroxychloroquine also significantly mitigated TNF-α induced impairment of angiogenesis. These findings support the further assessment of hydroxychloroquine as an adjuvant therapy in preeclampsia.
Related Topics
Health Sciences
Medicine and Dentistry
Cardiology and Cardiovascular Medicine
Authors
Rahana Rahman, Padma Murthi, Harmeet Singh, Seshini Gurusinghe, Joanne C. Mockler, Rebecca Lim, Euan M. Wallace,